Global Neurovascular Devices/Interventional Neurology Market Forecast 2023-2032

Global Neurovascular Devices/Interventional Neurology Market Forecast 2023-2032


KEY FINDINGS

The global neurovascular devices/interventional neurology market is anticipated to register a CAGR of 5.23% during the forecast period. The market’s growth is attributed to key drivers, such as the rising incidence of neurological conditions across the world, the surging preference for minimally invasive procedures, the geriatric population’s vulnerability to neurovascular diseases, and underlying diseases increasing the risk of neurovascular conditions.

MARKET INSIGHTS

Neurovascular disorders are linked to the blood vessels that supply oxygenated blood to the brain and spinal cord. Any disruption in blood flow can lead to impaired brain function, posing life-threatening risks. Immediate medical attention is essential for these conditions. Factors like intracranial stenosis, high bad cholesterol, hypertension, and diabetes contribute to neurovascular diseases.

For example, elevated bad cholesterol levels can cause plaque deposition in intracranial arteries, leading to stenosis and increasing the risk of ischemic stroke. Prompt treatment using neurovascular devices becomes crucial in managing these conditions, driving the growth of the market. Additionally, hypertension, a major cause of ischemic stroke, can result in blood clots that block arteries supplying the brain, leading to a stroke. As a result, underlying diseases leading to the increased risk of neurovascular conditions are expected to contribute to the global neurovascular devices/interventional neurology market growth during the forecast period.

REGIONAL INSIGHTS

The global neurovascular devices/interventional neurology market growth assessment entails the analysis of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to capture the highest revenue share by 2032, with the region’s growth ascribed to the increase in neurovascular illnesses as well as high investments in cutting-edge medical technologies.

COMPETITIVE INSIGHTS

The industry rivalry is set to increase during the forecasted period as key players in the global neurovascular devices/interventional neurology market implement various strategies to augment their market shares. Accordingly, some of the top companies in the market are Medtronic Inc, Memry Corporation, Penumbra Inc, MicroPort Scientific Corporation, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1.Study Objectives
1.2.Methodology
1.3.Assumptions & Limitations
2. Executive Summary
2.1.Market Size & Estimates
2.2.Market Overview
2.3.Scope Of Study
2.4.Crisis Scenario Analysis
2.4.1. Impact Of Covid-19 On Neurovascular Devices/Interventional Neurology Market
2.5.Major Market Findings
2.5.1. Government Initiatives To Create Awareness About Neurovascular Diseases
2.5.2. Early Detection Of Arteriovenous Malformation (Avm)
2.5.3. Thrombectomy Improves Patient Outcomes And Reduces Disability Rate
3. Market Dynamics
3.1.Key Drivers
3.1.1. Significant Rise In Incidence Of Neurovascular Conditions
3.1.2. Preference For Minimally Invasive Procedures
3.1.3. Geriatric Population’s Vulnerability To Neurovascular Diseases
3.1.4. Underlying Diseases Are A Risk Factor For Neurovascular Diseases
3.2.Key Restraints
3.2.1. Exorbitant Costs Of Neurovascular Devices
3.2.2. Lack Of Trained Neurosurgeons
4. Key Analytics
4.1.Key Market Trends
4.2.Porter’s Five Forces Analysis
4.2.1. Buyers Power
4.2.2. Suppliers Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3.Growth Prospect Mapping
4.3.1. Growth Prospect Mapping For United States
4.3.2. Growth Prospect Mapping For United Kingdom
4.3.3. Growth Prospect Mapping For Thailand
4.3.4. Growth Prospect Mapping For Middle East & Africa
4.4.Market Maturity Analysis
4.5.Market Concentration Analysis
4.6.Value Chain Analysis
5. Market By Product
5.1.Embolization Devices
5.1.1. Embolic Coils
5.1.1.1. Coated Detachable Coils
5.1.1.2. Bare Detachable Coils
5.1.2. Coil Assist Stent
5.1.3. Clippings
5.1.4. Coil Assist Balloon
5.2.Accessory Devices
5.2.1. Microcatheters
5.2.2. Micro Guidewires
5.3.Revascularization Devices
5.3.1. Carotid Artery Stents
5.3.2. Flow Diversion Stents
5.4.Thrombectomy Devices
5.4.1. Clot Retrieval Devices
5.4.2. Suction And Aspiration Devices
5.4.3. Snares
5.5.Embolic Protection Devices
5.5.1. Balloon Occlusion Devices
5.5.2. Distal Filter Devices
6. Market By Application
6.1.Aneurysm
6.2.Ischemic Stroke
6.3.Stenosis
6.4.Arteriovenous Malformation (Avm)
6.5.Other Applications
7. Geographical Analysis
7.1.North America
7.1.1. Market Size & Estimates
7.1.2. North America Neurovascular Devices/Interventional Neurology Market Drivers
7.1.3. North America Neurovascular Devices/Interventional Neurology Market Challenges
7.1.4. North America Neurovascular Devices/Interventional Neurology Market Regulatory Framework
7.1.5. Key Players In North America Neurovascular Devices/Interventional Neurology Market
7.1.6. Country Analysis
7.1.6.1. United States
7.1.6.1.1. United States Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.1.6.2. Canada
7.1.6.2.1. Canada Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.Europe
7.2.1. Market Size & Estimates
7.2.2. Europe Neurovascular Devices/Interventional Neurology Market Drivers
7.2.3. Europe Neurovascular Devices/Interventional Neurology Market Challenges
7.2.4. Europe Neurovascular Devices/Interventional Neurology Market Regulatory Framework
7.2.5. Key Players In Europe Neurovascular Devices/Interventional Neurology Market
7.2.6. Country Analysis
7.2.6.1. United Kingdom
7.2.6.1.1. United Kingdom Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.2. Germany
7.2.6.2.1. Germany Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.3. France
7.2.6.3.1. France Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.4. Italy
7.2.6.4.1. Italy Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.5. Spain
7.2.6.5.1. Spain Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.6. Poland
7.2.6.6.1. Poland Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.7. Belgium
7.2.6.7.1. Belgium Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.2.6.8. Rest Of Europe
7.2.6.8.1. Rest Of Europe Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.Asia-pacific
7.3.1. Market Size & Estimates
7.3.2. Asia-pacific Neurovascular Devices/Interventional Neurology Market Drivers
7.3.3. Asia-pacific Neurovascular Devices/Interventional Neurology Market Challenges
7.3.4. Asia-pacific Neurovascular Devices/Interventional Neurology Market Regulatory Framework
7.3.5. Key Players In Asia-pacific Neurovascular Devices/Interventional Neurology Market
7.3.6. Country Analysis
7.3.6.1. China
7.3.6.1.1. China Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.2. Japan
7.3.6.2.1. Japan Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.3. India
7.3.6.3.1. India Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.4. South Korea
7.3.6.4.1. South Korea Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.5. Indonesia
7.3.6.5.1. Indonesia Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.6. Thailand
7.3.6.6.1. Thailand Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.7. Vietnam
7.3.6.7.1. Vietnam Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.8. Australia & New Zealand
7.3.6.8.1. Australia & New Zealand Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.3.6.9. Rest Of Asia-pacific
7.3.6.9.1. Rest Of Asia-pacific Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.4.Rest Of World
7.4.1. Market Size & Estimates
7.4.2. Rest Of World Neurovascular Devices/Interventional Neurology Market Drivers
7.4.3. Rest Of World Neurovascular Devices/Interventional Neurology Market Challenges
7.4.4. Rest Of World Neurovascular Devices/Interventional Neurology Market Regulatory Framework
7.4.5. Key Players In Rest Of World Neurovascular Devices/Interventional Neurology Market
7.4.6. Regional Analysis
7.4.6.1. Latin America
7.4.6.1.1. Latin America Neurovascular Devices/Interventional Neurology Market Size & Opportunities
7.4.6.2. Middle East & Africa
7.4.6.2.1. Middle East & Africa Neurovascular Devices/Interventional Neurology Market Size & Opportunities
8. Competitive Landscape
8.1.Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions & Divestitures
8.2.Company Profiles
8.2.1. Acandis Gmbh
8.2.1.1. Company Overview
8.2.1.2. Product List
8.2.2. Asahi Intecc
8.2.2.1. Company Overview
8.2.2.2. Product List
8.2.3. Balt
8.2.3.1. Company Overview
8.2.3.2. Product List
8.2.4. B Braun Melsungen Ag
8.2.4.1. Company Overview
8.2.4.2. Product List
8.2.4.3. Strengths & Challenges
8.2.5. Integer Holdings Corporation
8.2.5.1. Company Overview
8.2.5.2. Product List
8.2.5.3. Strengths & Challenges
8.2.6. Johnson & Johnson (Cerenovus)
8.2.6.1. Company Overview
8.2.6.2. Product List
8.2.6.3. Strengths & Challenges
8.2.7. Kaneka Corporation
8.2.7.1. Company Overview
8.2.7.2. Product List
8.2.8. Medtronic Inc
8.2.8.1. Company Overview
8.2.8.2. Product List
8.2.8.3. Strengths & Challenges
8.2.9. Memry Corporation
8.2.9.1. Company Overview
8.2.9.2. Product List
8.2.10. Microport Scientific Corporation
8.2.10.1. Company Overview
8.2.10.2. Product List
8.2.10.3. Strengths & Challenges
8.2.11. Penumbra Inc
8.2.11.1. Company Overview
8.2.11.2. Product List
8.2.12. Phenox Inc
8.2.12.1. Company Overview
8.2.12.2. Product List
8.2.12.3. Strengths & Challenges
8.2.13. Rapid Medical
8.2.13.1. Company Overview
8.2.13.2. Product List
8.2.13.3. Strengths & Challenges
8.2.14. Sensome
8.2.14.1. Company Overview
8.2.14.2. Product List
8.2.14.3. Strengths & Challenges
8.2.15. Stryker Corporation
8.2.15.1. Company Overview
8.2.15.2. Product List
8.2.15.3. Strengths & Challenges
8.2.16. Terumo Corporation
8.2.16.1. Company Overview
8.2.16.2. Product List
8.2.16.3. Strengths & Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings